A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects

NCT01720537 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

BIOLOGICAL: PF-05335810 Dose A
BIOLOGICAL: PF-05335810 Dose B
BIOLOGICAL: Placebo
BIOLOGICAL: PF-05335810 Dose B
BIOLOGICAL: Placebo
BIOLOGICAL: PF-04950615 Dose A
BIOLOGICAL: PF-04950615 Dose A
BIOLOGICAL: PF-05335810 Dose C
BIOLOGICAL: Placebo
BIOLOGICAL: PF-05335810 Dose C
BIOLOGICAL: Placebo
BIOLOGICAL: PF-04950615
BIOLOGICAL: PF-05335810 Dose D
BIOLOGICAL: Placebo
BIOLOGICAL: PF-05335810 Dose E
BIOLOGICAL: PF-05335810 Dose D
BIOLOGICAL: Placebo

Sponsor

Pfizer